Novartis India reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported total income from operation (net) of INR 2,246.4 million compared to INR 2,338.0 million a year ago. Loss from operations before other income and finance costs was INR 15.5 million compared to profit from operations before other income and finance costs of INR 222.9 million a year ago. Profit from ordinary activates before tax was INR 215.6 million compared to INR 416.8 million a year ago. Net profit for the period was INR 152.3 million compared to INR 290.0 million a year ago. Basic and diluted earnings per share were INR 4.77 compared to INR 9.07 a year ago. The company reported net sales of INR 2,185.4 million for the quarter ended December, a fall of 4.3% year on year.

For the nine months, the company reported total income from operation (net) of INR 6,616.6 million compared to INR 6,907.7 million a year ago. Loss from operations before other income and finance costs was INR 114.0 million compared to profit from operations before other income and finance costs of INR 789.4 million a year ago. Profit from ordinary activates before tax was INR 576.4 million compared to INR 1,396.6 million a year ago. Net profit for the period was INR 746.5 million compared to INR 953.2 million a year ago. Basic and diluted earnings per share were INR 23.36 compared to INR 29.82 a year ago.